Your browser doesn't support javascript.
loading
Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development.
Abd-Rahman, Azrin N; Zaloumis, Sophie; McCarthy, James S; Simpson, Julie A; Commons, Robert J.
Afiliación
  • Abd-Rahman AN; QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Queensland, Australia.
  • Zaloumis S; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbournegrid.1008.9, Parkville, Victoria, Australia.
  • McCarthy JS; The Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9 and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Simpson JA; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbournegrid.1008.9, Parkville, Victoria, Australia.
  • Commons RJ; Global Health Division, Menzies School of Health Researchgrid.271089.5 and Charles Darwin University, Darwin, Northern Territory, Australia.
Antimicrob Agents Chemother ; 66(2): e0165921, 2022 02 15.
Article en En | MEDLINE | ID: mdl-34843390
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Antimaláricos Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Antimaláricos Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Australia